| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Humacyte, Inc. | Chief Commercial Officer | Common Stock | 22,018 | $33,908 | $1.54 | 14 Apr 2025 | Direct |
| Humacyte, Inc. | Chief Commercial Officer | Stock Options (right to buy) | 283,101 | 21 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HUMA | Humacyte, Inc. | 14 Apr 2025 | 1 | +$9,999 | 4 | Chief Commercial Officer | 15 Apr 2025, 16:03 |
| HUMA | Humacyte, Inc. | 21 Jan 2025 | 1 | $0 | 4 | Chief Commercial Officer | 23 Jan 2025, 16:34 |
| HUMA | Humacyte, Inc. | 08 Dec 2023 | 1 | $0 | 4 | Chief Commercial Officer | 12 Dec 2023, 16:10 |
| HUMA | Humacyte, Inc. | 13 Dec 2022 | 1 | +$15,450 | 4 | Chief Commercial Officer | 15 Dec 2022, 18:53 |
| HUMA | Humacyte, Inc. | 08 Dec 2022 | 1 | $0 | 4 | Chief Commercial Officer | 12 Dec 2022, 15:15 |
| HUMA | Humacyte, Inc. | 24 May 2022 | 1 | +$49,678 | 4 | Chief Commercial Officer | 25 May 2022, 11:46 |
| HUMA | Humacyte, Inc. | 13 Oct 2021 | 1 | $0 | 4 | Chief Commercial Officer | 15 Oct 2021, 15:51 |
| HUMA | Humacyte, Inc. | 26 Aug 2021 | 0 | $0 | 3 | Chief Commercial Officer | 27 Aug 2021, 16:06 |